Inventor
YOON TAEYOUNG
US30 patents
⚠️ This page may combine multiple inventors who share the name “YOON TAEYOUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROGEN CORP
18 patentsUS6114530ASep 5, 2000
Isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands
NEUROGEN CORP17 citations92
US7566712B2Jul 28, 2009
Biaryl piperazinyl-pyridine analogues
NEUROGEN CORP11 citations84
US7304059B2Dec 4, 2007
Substituted quinazolin-4-ylamine analogues
NEUROGEN CORP10 citations83
US7223778B2May 29, 2007
5-substituted-2-arylpyridines
NEUROGEN CORP15 citations79
US6583169B2Jun 24, 2003
N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives
NEUROGEN CORP6 citations74
US6353103B1Mar 5, 2002
Isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands
NEUROGEN CORP11 citations74
US6281237B1Aug 28, 2001
N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives
NEUROGEN CORP7 citations74
US6235752B1May 22, 2001
Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptors
NEUROGEN CORP4 citations74
US6995161B2Feb 7, 2006
Substituted arylpyrazines
NEUROGEN CORP7 citations72
US6953801B2Oct 11, 2005
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
NEUROGEN CORP11 citations72
US7179807B2Feb 20, 2007
5-substituted-2-arylpyrazines
NEUROGEN CORP7 citations71
US7148225B2Dec 12, 2006
Substituted biaryl amides as C5A receptor modulators
NEUROGEN CORP7 citations71
US6858637B2Feb 22, 2005
Substituted biaryl amides as C5a receptor modulators
NEUROGEN CORP1 citations62
US6495686B2Dec 17, 2002
Pyrimido [4,5,b]indolizine derivatives and aza analogues thereof; CRF1 specific ligands
NEUROGEN CORP1 citations52
US6440969B2Aug 27, 2002
Certain isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands
NEUROGEN CORP0 citations52
US6194574B1Feb 27, 2001
Pyrido[2,3-b]indolizine derivatives and aza analogues thereof: CRF1 specific ligands
NEUROGEN CORP1 citations52
US7202250B2Apr 10, 2007
Substituted arylpyrazines
NEUROGEN CORP0 citations51
US7241765B2Jul 10, 2007
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
NEUROGEN CORP0 citations50
DONG A SOCIO HOLDINGS CO LTD
5 patentsUS10913730B2Feb 9, 2021
Heteroaryl compounds and their use as Mer inhibitors
DONG A SOCIO HOLDINGS CO LTD2 citations70
US12378224B2Aug 5, 2025
Heteroaryl compounds and their use as Mer inhibitors
DONG A SOCIO HOLDINGS CO LTD0 citations59
US12195446B2Jan 14, 2025
Heteroaryl compounds and their use as therapeutic drugs
DONG A SOCIO HOLDINGS CO LTD0 citations58
US10947215B2Mar 16, 2021
Heteroaryl compounds and their use as therapeutic drugs
DONG A SOCIO HOLDINGS CO LTD0 citations58
US10125118B2Nov 13, 2018
Heteroaryl compounds and their use as therapeutic drugs
DONG A SOCIO HOLDINGS CO LTD0 citations48